These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15972276)

  • 1. Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes.
    Pitini V; Arrigo C; Amata C; La Torre I
    Ann Oncol; 2005 Nov; 16(11):1845; author reply 1845-6. PubMed ID: 15972276
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
    Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
    Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
    Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
    Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
    Stathopoulos EN; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
    Ann Oncol; 2005 Feb; 16(2):240-6. PubMed ID: 15668277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sentinel lymph node biopsy in breast cancer].
    Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.
    Kahn HJ; Yang LY; Blondal J; Lickley L; Holloway C; Hanna W; Narod S; McCready DR; Seth A; Marks A
    Breast Cancer Res Treat; 2000 Mar; 60(2):143-51. PubMed ID: 10845277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
    Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
    Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
    Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
    J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
    Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
    Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of RT-PCR in detection of axillary lymph node micrometastases from breast cancer].
    Hao XB; Fu J; Qiu FH
    Ai Zheng; 2003 Sep; 22(9):964-7. PubMed ID: 12969530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel diagnostic procedure for determining metastasis to sentinel lymph nodes in breast cancer using a semi-dry dot-blot method.
    Otsubo R; Oikawa M; Hirakawa H; Shibata K; Abe K; Hayashi T; Kinoshita N; Shigematsu K; Hatachi T; Yano H; Matsumoto M; Takagi K; Tsuchiya T; Tomoshige K; Nakashima M; Taniguchi H; Omagari T; Itoyanagi N; Nagayasu T
    Int J Cancer; 2014 Feb; 134(4):905-12. PubMed ID: 23913465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
    Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
    Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.
    Banerjee SM; Williams NR; Davidson TI; El Sheikh S; Tran-Dang M; Davison S; Ghosh D; Keshtgar MR
    Eur J Surg Oncol; 2016 May; 42(5):641-9. PubMed ID: 26979647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics.
    Silva JM; Dominguez G; Silva J; Garcia JM; Sanchez A; Rodriguez O; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2001 Sep; 7(9):2821-5. PubMed ID: 11555599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.